BDTX

Black Diamond Therapeutics, Inc.

Contracts

Total Value

Stock Metrics

11.2%

Short % Float

8.7d to cover · Moderate squeeze

71.9%

Inst % Float

10 holders · 2026-06-30

T. Rowe Price Inve

Top Holder

18.4% of float

52.5M sh

Public Float

27/100

Dilution Score

Medium

24+ mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

27/100

MEDIUM

Inst: 71.87% · Top: T. Rowe Price Investment Management, Inc.

Biotech Analytics

Biotech / Pharma

22.24

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk27

Clinical Trials29

Short Interest50